![Jennifer Schmitke](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jennifer Schmitke formerly worked at Biogen, Inc., as Senior Director, Epizyme, Inc., as SVP-Technical Operations & Quality, Magenta Therapeutics, Inc., as Vice President & Head-Program Management, Omega Therapeutics, Inc., as Vice President, and IMV, Inc., as Chief Operating Officer.
Dr. Schmitke received her undergraduate degree from Queen's University and doctorate degree from Massachusetts Institute of Technology.
| Companies | Position | End |
|---|---|---|
| IMV INC. | Chief Operating Officer | 30/04/2023 |
| EPIZYME, INC. | Corporate Officer/Principal | 31/03/2022 |
| BIOGEN INC. | Director/Board Member | - |
| OMEA THER | Corporate Officer/Principal | - |
| MAGENTA THERAPEUTICS | Corporate Officer/Principal | - |
Active
Inactive
Listed companies
Private companies
| Private companies | 7 |
|---|---|
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Queen's University
 Queen's University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Epizyme, Inc.
 Epizyme, Inc. BiotechnologyHealth Technology Develops therapeutics for the treatment of patients with genetically defined cancers | Health Technology |
IMV, Inc.
 IMV, Inc. BiotechnologyHealth Technology Operates as a clinical-stage immuno-oncology company | Health Technology |
Magenta Therapeutics, Inc.
 Magenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel medicines | Health Technology |
Omega Therapeutics, Inc.
 Omega Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for general and rare genetic diseases, immunology, inflammation, oncology and metabolic diseases | Health Technology |
Select your edition
All financial news and data tailored to specific country editions
Choose MarketScreener 
